Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

AptarGroup stock PT lifted by Wells Fargo on pharma growth prospects

Published 29/04/2024, 12:10
ATR
-

On Monday, Wells Fargo (NYSE:WFC) adjusted its outlook for AptarGroup (NYSE:ATR), a company specializing in a range of packaging, dispensing, and sealing solutions. The firm raised its price target on the stock to $163.00, up from the previous target of $160.00, while reiterating an Overweight rating.

The revision reflects AptarGroup's continued strong performance in the pharmaceutical sector, despite challenging comparisons with the previous year's results. According to the firm, AptarGroup is effectively capitalizing on a robust product pipeline, and its expanded capacity is anticipated to support growth momentum through 2025.

Additionally, the company's Beauty & Closures segment is reportedly seeing benefits from both improved market conditions and internal initiatives.

Wells Fargo's confidence in the stock is also tied to the belief that investors will increasingly value AptarGroup's flourishing pharmaceutical business, which could lead to a higher valuation multiple. The firm's earnings per share (EPS) estimates for AptarGroup have been updated to $5.30 for 2024 and $5.65 for 2025, adjusted from the previous estimates of $5.20 and $5.70, respectively.

The price target increase is based on a 15 times multiple of the firm's estimated earnings before interest, taxes, depreciation, and amortization (EBITDA) for 2024. AptarGroup's performance and strategic positioning in the market segments it serves appear to be the driving factors behind this optimistic financial forecast.

InvestingPro Insights

Following Wells Fargo's upward revision of AptarGroup's price target, it's worth noting some key metrics and insights from InvestingPro that could further inform investors about the company's financial health and market position. AptarGroup boasts a solid track record of dividend reliability, having maintained dividend payments for an impressive 32 consecutive years. This consistency is a testament to the company's stability and commitment to shareholder returns.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Moreover, the company's P/E ratio stands at 30.76, with an adjusted P/E ratio for the last twelve months as of Q1 2024 at a slightly lower 27.58. This indicates that while the stock is trading at a high earnings multiple, it may still offer potential for investors looking at near-term earnings growth. The company also showcases a robust gross profit margin of 36.51% for the same period, underscoring its efficiency in managing production costs and profitability.

For those considering an investment in AptarGroup, there are additional InvestingPro Tips available that provide a comprehensive analysis of the company's financials, market performance, and future outlook. With the use of the coupon code PRONEWS24, investors can enjoy an extra 10% off a yearly or biyearly Pro and Pro+ subscription to access these valuable insights. Currently, there are 6 more InvestingPro Tips listed for AptarGroup that could further guide investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.